mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.1 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.1 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.2 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.2 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.39 |
0.2 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |